medic
therapi
pss
consist
dietari
modif
antibiot
therapi
lactulos
goal
decreas
nh
product
lowprotein
diet
consist
highqual
digest
protein
recommend
commerci
avail
liver
diseas
diet
homecook
diet
chicken
cottag
chees
rice
pasta
typic
fed
feed
smaller
portion
frequent
may
benefici
ampicillin
mgkg
intraven
iv
everi
hour
metronidazol
mgkg
mouth
twice
day
commonli
use
decreas
nh
produc
bacteria
lactulos
acidifi
colon
content
lead
convers
nh
nh
lactulos
also
decreas
fecal
transit
time
therebi
speed
elimin
bacteria
nh
lactulos
given
effect
produc
soft
stool
gastrointestin
ulcer
increas
risk
patient
pss
thu
gastric
protect
famotidin
mgkg
mouth
twice
day
omeprazol
mgkg
mouth
everi
hour
given
anticonvuls
therapi
indic
seizur
present
given
periop
surgic
ligationconstrict
recommend
possibl
surgeri
redirect
flow
blood
hepat
parenchyma
variou
techniqu
avail
includ
surgic
ligat
partial
ligat
use
devic
gradual
occlud
aberr
vessel
ameroid
constrictor
cellophan
band
use
ameroid
constrictor
cellophan
band
decreas
mortal
associ
surgeri
surgic
therapi
typic
consid
superior
medic
therapi
howev
therapi
benefici
studi
compar
surgic
therapi
medic
therapi
indic
shuntrel
mortal
dog
treat
surgic
versu
shuntrel
mortal
dog
treat
medic
periop
mortal
studi
postop
seizur
report
dog
surgic
typic
occur
within
day
surgeri
neurolog
sign
may
occur
decreas
circul
endogen
benzodiazepin
ligand
imbal
excitatori
inhibitori
neurotransmitt
hypoglycemia
postop
gener
seizur
associ
high
mortal
wherea
dog
postop
partial
seizur
typic
respond
therapi
although
phenobarbit
therapi
significantli
reduc
incid
seizur
seem
reduc
sever
seizur
studi
none
dog
treat
levetiracetam
mgkg
mouth
time
day
postop
seizur
one
studi
hydrocephalu
increas
cerebrospin
fluid
csf
volum
consid
toy
brachiocephal
breed
domeshap
head
persist
fontanel
may
present
stenosi
mesencephal
aqueduct
common
caus
hydrocephalu
stenosi
typic
result
fusion
rostral
colliculi
csf
accumul
rostral
obstruct
cerebr
cortic
atrophi
occur
tear
ependym
cell
periventricular
diverticula
occur
dilat
ventricular
system
hydrocephalu
may
also
result
neoplasia
infect
obstruct
csf
flow
hydrocephalu
report
secondari
leiomyosarcoma
chihuahua
cat
may
develop
hydrocephalu
secondari
infecti
caus
felin
infecti
periton
fip
hydrocephalu
result
autosom
recess
inherit
siames
cat
degre
clinic
sign
hydrocephalu
variabl
hydrocephal
anim
asymptomat
ventriculomegali
common
incident
find
toy
brachiocephal
breed
clinic
sign
result
alter
intracrani
pressur
loss
cortic
neuron
neuron
function
periventricular
edema
secondari
abnorm
csf
flow
across
ventricular
wall
clinic
sign
depend
anatom
locat
affect
cerebr
vestibular
cerebellar
sign
seen
ventral
andor
later
strabismu
occur
skull
orbit
deform
increas
pressur
mesencephal
tegmentum
fig
thin
calvarium
decreas
cerebr
tissu
chang
cerebr
vascular
caus
hydrocephal
anim
sensit
head
trauma
hemorrhag
event
lead
acut
neurolog
deterior
chronic
subdur
hematoma
identifi
hydrocephal
dog
diagnosi
made
via
cranial
magnet
reson
imag
mri
ct
scan
ultrasound
persist
fontanel
may
also
use
diagnosi
fig
ct
scan
effect
evalu
ventricular
system
howev
beam
harden
artifact
obscur
evalu
brainstem
superior
soft
tissu
imag
mri
allow
detail
evalu
disord
mri
provid
superior
evalu
ventricular
system
brainstem
mri
help
rule
caus
hydrocephalu
infect
neoplasia
evalu
concurr
hemorrhag
fig
csf
analysi
import
rule
concurr
inflammatori
infecti
disord
medic
therapi
indic
hydrocephalu
caus
clinic
sign
medic
therapi
direct
decreas
csf
product
decreas
periventricular
edema
glucocorticoid
decreas
csf
product
decreas
nakatpas
activ
may
benefici
periventricular
edema
present
prednison
start
mgkg
mouth
twice
day
taper
lowest
effect
dose
omeprazol
also
decreas
csf
product
may
benefit
action
omeprazol
action
may
independ
nakatpas
inhibit
acetazolamid
carbon
anhydras
inhibitor
may
benefit
given
mgkg
mouth
everi
hour
electrolyt
monitor
acetazolamid
therapi
caus
hypokalemia
anticonvuls
therapi
indic
hydrocephalu
caus
seizur
surgic
placement
ventriculoperiton
shunt
consid
dog
progress
sign
respons
medic
therapi
fig
success
shunt
variabl
shunt
prove
effect
medic
therapi
howev
shunt
offer
possibl
longterm
control
clinic
sign
studi
ventriculoperiton
shunt
congenit
hydrocephalu
dog
cat
indic
improv
clinic
sign
patient
complic
occur
patient
typic
within
first
month
shunt
placement
median
followup
studi
month
thu
complic
could
higher
thirtysix
percent
patient
die
hydrocephalusrel
complic
euthan
postsurg
surviv
rate
surviv
rate
two
smaller
canin
studi
indic
postop
complic
rate
potenti
complic
shunt
includ
infect
occlus
shunt
undershunt
overshunt
shunt
migrat
valv
fractur
need
surgic
revis
common
peopl
shunt
failur
occur
hydrocephal
children
shunt
still
success
year
shunt
implant
common
reason
failur
shunt
obstruct
metabol
defect
caus
hydroxyglutar
aciduria
recogn
staffordshir
bull
terrier
west
highland
white
terrier
yorkshir
terrier
lave
hydroxyglutar
aciduria
autosom
recess
diseas
staffordshir
bull
terrier
genet
mutat
identifi
exon
chromosom
staffordshir
bull
terrier
mutat
differ
mutat
yorkshir
terrier
clinic
sign
hydroxyglutar
aciduria
includ
seizur
ataxia
stiff
gait
decreas
mentat
head
tremor
sign
occur
month
year
age
often
identifi
less
year
age
organ
acid
analysi
urin
csf
plasma
abnorm
affect
dog
mri
identifi
bilater
symmetr
diffus
hyperintens
imag
gray
matter
throughout
brain
effect
treatment
known
time
symptomat
anticonvuls
therapi
dietari
therapi
may
benefit
cobalamin
therapi
may
benefici
methylmalon
aciduria
peopl
cavali
king
charl
spaniel
report
seizur
secondari
hexanoylglycin
aciduria
lcarnitin
therapi
recommend
peopl
mediumchain
acyl
coenzym
dehydrogenas
defici
thu
may
benefit
hexanoylglycin
aciduria
lissencephali
congenit
abnorm
thought
occur
arrest
neuron
migrat
cortic
plate
fetal
develop
lissencephali
result
smooth
cerebr
cortic
surfac
gyri
sulci
fail
develop
cerebr
cortex
becom
thicker
normal
fusion
corpu
callosum
intern
capsul
caus
corona
radiata
white
matter
absent
lissencephali
commonli
report
lhasa
apso
also
report
wirehair
fox
terrier
irish
setter
korat
cat
seizur
common
may
seen
year
age
behavior
chang
circl
visual
deficit
may
also
seen
diagnosi
made
via
mri
fig
symptomat
anticonvuls
therapi
recommend
granulomat
meningoencephalomyel
gme
account
cn
disord
dog
young
middleag
smallbre
dog
commonli
affect
howev
age
breed
may
develop
gme
histolog
gme
character
perivascular
cuff
primarili
mononuclear
cell
within
white
matter
accumul
inflammatori
cell
typic
microscop
area
coalesc
form
focal
granulomat
mass
histolog
brainstem
commonli
involv
multifoc
diseas
common
region
cn
cerebrum
cerebellum
brainstem
cervic
spinal
cord
may
affect
ocular
gme
also
report
clinic
sign
vari
base
region
cn
involv
onset
may
acut
chronic
caus
gme
remain
unclear
cellmedi
delayedtyp
hypersensit
reaction
autoimmun
basi
suspect
infecti
caus
explor
identifi
combin
nonspecif
immunolog
respons
genet
environment
factor
consid
like
play
role
caus
gme
definit
diagnosi
gme
made
via
histopatholog
howev
presumpt
diagnosi
made
antemortem
absenc
brain
biopsi
via
combin
mri
csf
result
cbc
serum
chemistri
urinalysi
unremark
csf
singl
use
test
inflammatori
brain
diseas
csf
typic
yield
mononuclear
pleocytosi
increas
protein
howev
mix
pleocytosi
increas
percentag
neutrophil
common
csf
result
gme
sometim
mimic
result
inflammatori
brain
diseas
brain
imag
help
differenti
gme
inflammatori
brain
diseas
necrot
meningoenceph
nme
necrot
leukoenceph
nle
nme
nle
characterist
abnorm
mri
present
help
differenti
gme
gme
mri
result
often
identifi
edema
hyperintens
lesion
fluidattenu
invers
recoveri
flair
contrastenhanc
lesion
fig
mri
abnorm
typic
locat
within
white
matter
consist
histolog
distribut
diseas
time
patient
gme
normal
mri
result
mainstay
treatment
corticosteroid
prednison
use
treat
cn
edema
well
suppress
immun
system
rapidli
deterior
dog
dysphag
dog
dexamethason
sodium
phosphat
mgkg
iv
subcutan
everi
hour
twice
day
given
prednison
mgkg
mouth
twice
day
later
given
sever
refractori
case
cytosin
arabinosid
may
given
mgm
twice
day
consecut
day
repeat
necessari
everi
week
altern
procarbazin
mgm
mouth
everi
hour
cyclosporin
mgkg
mouth
twice
day
may
given
routin
monitor
cbc
done
drug
given
serial
urinalysi
without
cultur
also
recommend
immunosuppress
dog
clinic
sign
serial
csf
evalu
use
assess
therapeut
success
prednison
taper
period
sever
month
mani
dog
requir
longterm
prednison
therapi
adjunct
therapi
cytosin
arabinosid
cyclosporin
procarbazin
may
lessen
depend
corticosteroid
lead
favor
prognosi
prognosi
gme
consid
guard
median
surviv
time
dog
focal
sign
day
wherea
dog
multifoc
sign
median
surviv
time
day
one
studi
recent
studi
shown
better
prognosi
one
studi
report
median
surviv
time
month
procarbazin
prednison
treatment
compar
month
dog
receiv
treatment
anoth
studi
show
median
surviv
time
day
use
cyclosporin
combin
corticosteroid
ketoconazol
studi
compar
use
lomustin
prednisolon
prednisolon
alon
yield
median
surviv
time
day
compar
day
respect
differ
surviv
time
group
statist
signific
studi
evalu
use
cytosin
arabinosid
prednison
dog
inflammatori
brain
diseas
unknown
caus
indic
median
surviv
time
day
studi
includ
dog
suspect
gme
well
nme
nle
nme
inflammatori
diseas
caus
necrot
cystic
lesion
within
gray
white
matter
cerebrum
pug
chihuahua
maltes
terrier
shih
tzu
papillon
necrot
condit
often
adjac
cerebr
graywhit
matter
junction
yorkshir
terrier
nle
caus
necrot
white
matter
lesion
cerebrum
typic
inflammatori
lesion
brainstem
cerebellum
breedspecif
varianc
lesion
locat
uncertain
whether
diseas
variant
diseas
differ
diseas
nme
nle
also
report
pekinges
french
bulldog
male
femal
young
middleag
dog
typic
affect
howev
dog
old
year
age
report
seizur
common
mentat
chang
circl
place
deficit
may
also
seen
vestibular
sign
may
predomin
brainstem
affect
nle
csf
typic
indic
mononuclear
pleocytosi
increas
protein
howev
time
csf
normal
mri
help
confirm
locat
presenc
cavit
lesion
mri
may
also
differenti
diseas
gme
lesion
nme
multifoc
asymmetr
present
graywhit
matter
junction
typic
hyperintens
flair
imag
isointens
hypointens
imag
contrast
enhanc
variabl
fig
nle
lesion
typic
asymmetr
multifoc
affect
subcort
white
matter
lesion
hyperintens
flair
imag
isointens
hypointens
imag
contrast
enhanc
also
variabl
fig
recommend
treatment
prednison
mgkg
mouth
twice
day
gradual
reduct
dose
respons
therapi
occur
prognosi
necrot
enceph
poor
mean
surviv
time
corticosteroid
treatment
day
one
studi
dog
necrot
enceph
may
less
respons
therapi
treat
suspect
gme
infecti
diseas
nervou
system
like
puppi
kitten
compar
adult
poor
suckl
lead
malnutrit
incomplet
transfer
matern
antibodi
difficult
parturit
environment
stress
concurr
diseas
process
parvoviru
weaken
immun
system
increas
chanc
bacteri
meningoenceph
anim
bacteri
meningoenceph
may
fever
leukocytosi
lethargi
appar
back
pain
may
also
present
thorough
examin
abdomin
ultrasound
thorac
radiograph
identifi
nidu
infect
infect
aris
dermal
lesion
recent
surgic
procedur
hematogen
spread
cn
otiti
media
interna
spread
central
brain
lead
bacteri
mening
csf
result
bacteri
meningoenceph
neutrophil
howev
sever
neutrophil
pleocytosi
also
seen
noninfecti
inflammatori
diseas
steroidrespons
mening
arter
mri
may
identifi
mening
enhanc
abscess
format
otiti
media
interna
consist
infecti
process
make
steroidrespons
mening
arter
less
like
fig
cultur
csf
andor
urin
may
help
identifi
bacteri
caus
visual
bacteria
csf
allow
definit
diagnosi
bacteri
meningoenceph
staphylococcu
escherichia
coli
streptococcu
variou
anaerob
typic
present
bacteri
meningoenceph
cn
penetr
often
consider
choos
antibiot
first
compromis
bloodbrain
barrier
allow
better
penetr
cn
blood
barrier
intact
antibiot
penetr
may
difficult
thu
longer
cours
antibiot
therapi
higher
dosag
choos
antibiot
reliabl
penetr
cn
may
requir
chloramphenicol
reach
high
cn
concentr
typic
use
potenti
advers
effect
particularli
neonat
doxycyclin
penetr
cn
bacteriostat
natur
concern
use
young
anim
consid
trimethoprimsulfa
also
reach
high
cn
concentr
concern
regard
potenti
advers
effect
also
limit
use
amoxicillin
clavulan
acid
broad
spectrum
reach
low
csf
concentr
bloodbrain
barrier
intact
fluoroquinolon
good
choic
staphylococcu
e
coli
variabl
effect
streptococcu
also
reach
low
csf
concentr
fig
transvers
postcontrast
mri
contrast
enhanc
present
ventrolater
brainstem
consist
infecti
process
rather
steroidrespons
mening
arter
canin
distemp
viru
cdv
singlestrand
rna
morbilliviru
typic
spread
aerosol
rout
cdv
epitheliotrop
respiratori
system
initi
infect
subsequ
spread
cn
integu
bladder
intestin
tract
cdv
enter
nervou
system
csf
cross
bloodbrain
barrier
via
infect
mononuclear
cell
multifoc
lesion
common
primari
demyelin
often
occur
white
matter
although
gray
matter
also
affect
area
brain
commonli
affect
includ
cerebellum
periventricular
white
matter
optic
pathway
spinal
cord
clinic
sign
typic
seen
dog
less
year
old
persist
viral
infect
lead
chronic
form
socal
olddog
distemp
outbreak
may
occur
particularli
anim
shelter
caus
crowd
condit
divers
popul
stress
studi
florida
anim
shelter
indic
dog
admit
shelter
protect
antibodi
titer
pat
distemp
age
whether
dog
neuter
associ
pat
seventyf
percent
dog
year
old
pat
compar
dog
less
year
old
neuter
dog
time
like
pat
intact
dog
vaccin
reduc
incid
case
occur
vaccin
dog
neurolog
sign
typic
focal
despit
multifoc
lesion
seizur
myoclonu
common
neurolog
sign
brainstem
cerebellar
myelopath
sign
may
also
seen
myoclonu
may
caus
hyperexcit
lower
motor
neuron
may
persist
sleep
disappear
anesthesia
diagnosi
cdv
often
base
clinic
sign
combin
neurolog
abnorm
particularli
myoclonu
extraneur
sign
lead
high
suspicion
cdv
extraneur
sign
common
includ
pneumonia
enter
conjunct
rhiniti
discolor
teeth
hyperkeratosi
nasal
planum
foot
pad
pulmonari
infiltr
often
identifi
thorac
radiograph
csf
often
identifi
mononuclear
pleocytosi
albuminocytolog
disassoci
normal
csf
analysi
occur
serolog
typic
help
prior
vaccin
previou
subclin
infect
sever
cdv
infect
sometim
low
titer
immunosuppress
direct
immunofluoresc
test
conjunctiv
vagin
nasal
smear
confirm
cdv
within
week
infect
polymeras
chain
reaction
pcr
test
help
pcr
test
may
done
csf
blood
conjunctiva
urin
revers
transcriptas
pcr
rtpcr
consid
best
antemortem
method
use
detect
cdv
rtpcr
detect
cdv
rna
infect
dog
via
whole
blood
csf
test
infect
dog
via
serum
test
one
studi
dog
test
posit
pcr
test
done
urin
twelv
asymptomat
dog
test
neg
vaccin
viru
identifi
coupl
day
vaccin
prognosi
distemp
infect
variabl
sever
affect
dog
like
die
wherea
mildli
affect
dog
may
recov
support
care
mainstay
therapi
anticonvuls
use
treat
seizur
antibiot
pneumonia
intraven
fluid
maintain
hydrat
concurr
toxoplasma
infect
may
occur
present
treat
neosporosi
neospora
caninum
protozo
parasit
primari
cn
neuromuscular
pathogen
dog
pneumonia
enceph
myocard
hepat
myonecrosi
predomin
lesion
neonat
ninetytwo
percent
affect
dog
less
year
old
transplacent
transmiss
major
rout
infect
ascend
paralysi
typic
present
sign
possibl
progress
cervic
brainstem
cerebellar
region
polyradiculoneur
polymyos
may
result
hyperextens
pelvic
limb
creatin
kinas
increas
polymyos
present
csf
abnorm
typic
includ
mononuclear
pleocytosi
diagnosi
support
via
serum
immunofluoresc
antibodi
ifa
titer
affect
dog
ifa
titer
greater
howev
clinic
normal
dog
titer
high
tachyzoit
identifi
cell
csf
dermal
lesion
bronchial
lavag
pcr
csf
posit
dog
one
report
clindamycin
mgkg
mouth
everi
hour
week
typic
use
neosporosi
therapi
although
trimethoprim
sulfonamid
mgkg
mouth
everi
hour
may
also
use
alon
concurr
clindamycin
clindamycin
effect
tachyzoit
like
ineffect
encyst
bradyzoit
despit
clinic
improv
n
caninum
infect
clear
bodi
prognosi
consid
poor
success
treatment
possibl
delay
therapi
muscl
fibrosi
pelvic
limb
hyperextens
consid
poor
prognost
indic
toxoplasma
gondii
protozo
parasit
transmit
via
ingest
sporul
oocyst
transplacent
undercook
meat
cat
definit
host
sever
sign
caus
transplacent
infect
kitten
kitten
may
stillborn
die
within
week
pulmonari
cn
cardiac
pancreat
hepat
ocular
lesion
common
clinic
infect
cat
brain
lesion
common
although
neurolog
sign
absent
mani
affect
cat
muscl
involv
uncommon
cat
toxoplasma
enceph
occur
peopl
acquir
immun
defici
syndrom
histopatholog
brain
lesion
common
histolog
examin
cat
lesion
one
studi
common
lesion
dissemin
glial
histiocyt
granuloma
mononuclear
perivascular
cuf
despit
frequenc
histolog
lesion
neurolog
sign
studi
uncommon
infect
cat
clinic
neurolog
abnorm
eighti
percent
brain
examin
brain
toxoplasma
organ
identifi
clinic
case
result
reactiv
infect
cat
older
month
age
posit
serolog
support
diagnosi
howev
cat
dog
gondii
antibodi
posit
immunoglobulin
ig
antibodi
indic
recent
infect
last
week
inocul
igm
antibodi
typic
seen
healthi
cat
correl
close
diseas
igg
antibodi
support
chronic
infect
csf
analysi
cn
toxoplasmosi
typic
show
mix
pleocytosi
increas
protein
pcr
test
done
directli
csf
toxoplasma
suspect
clindamycin
mgkg
mouth
everi
hour
week
treatment
choic
cryptococcu
neoforman
cryptococcu
gatti
saprophyt
yeastlik
fungi
characterist
heteropolysaccharid
capsul
provid
virul
resist
desicc
eight
molecular
type
describ
vn
type
c
neoforman
common
type
dog
vg
iii
type
c
gatti
common
cat
inhal
like
rout
infect
predilect
cn
occur
dog
cat
cat
cryptococcosi
cn
involv
age
predilect
present
cat
wherea
affect
dog
typic
less
year
age
cn
sign
depend
lesion
locat
cerebr
involv
particularli
olfactori
bulb
common
seizur
obtund
common
sign
vestibular
involv
common
system
abnorm
also
common
includ
chorioretin
nasal
discharg
skin
lesion
hilar
lymphadenopathi
renal
hepat
splenic
involv
therefor
thorough
fundic
examin
thorac
radiograph
abdomin
ultrasound
recommend
cryptococcosi
suspect
serum
latex
agglutin
la
test
highli
sensit
specif
la
test
sensit
specif
one
studi
neurolog
sign
posit
serum
la
test
suggest
cn
cryptococcosi
identif
organ
csf
posit
csf
la
test
confirm
diagnosi
neg
serum
la
test
posit
yeast
identif
posit
la
result
csf
possibl
mri
result
variabl
mri
may
identifi
gelatin
pseudocyst
hypointens
imag
hyperintens
imag
pseudocyst
may
peripher
contrast
enhanc
mening
ependym
choroid
plexu
contrast
enhanc
may
occur
case
increas
cellulargranulomat
respons
dog
compar
cat
may
correl
contrast
enhanc
pattern
identifi
mri
fig
azol
therapi
commonli
use
treatment
cryptococcosi
cryptococcosi
often
treat
success
twentyeight
cat
treat
fluconazol
success
outcom
howev
cn
involv
like
decreas
prognosi
fluconazol
good
csf
penetr
thu
recommend
cn
cryptococcosi
fluconazol
mg
mouth
twice
day
typic
use
cat
mgkg
per
day
divid
twice
day
use
dog
itraconazol
mgkg
per
day
may
also
use
success
outcom
occur
cat
improv
seen
cat
treat
itraconazol
one
studi
itraconazol
highli
protein
bound
insolubl
fluid
larger
fluconazol
seem
cross
blood
csf
barrier
detect
lave
amount
itraconazol
may
success
treat
cn
cryptococcosi
cross
inflam
bloodbrain
barrier
via
drug
accumul
within
highli
lipid
brain
immunosuppress
peopl
initi
treatment
cryptococc
mening
combin
intraven
amphotericin
b
oral
flucytosin
week
therapi
peopl
switch
azol
therapi
cryptococcu
suscept
amphotericin
b
howev
durat
use
limit
poor
cn
penetr
potenti
renal
toxic
daili
monitor
renal
valu
recommend
administ
amphotericin
b
lipidcomplex
amphotericin
b
increas
efficaci
less
nephrotox
standard
amphotericin
b
flucytosin
mgkg
mouth
everi
hour
cat
penetr
well
csf
use
singl
agent
resist
develop
quickli
flucytosin
caus
dermal
erupt
dog
prognosi
dog
cat
cryptococcosi
consid
wors
cn
involv
remiss
greater
year
occur
cat
dog
one
studi
abnorm
mentat
associ
poor
outcom
singledrug
therapi
versu
multipledrug
therapi
significantli
affect
outcom
use
glucocorticoid
improv
surviv
time
within
first
day
cn
mycos
often
caus
inflamm
edema
die
organ
caus
inflamm
neurolog
deterior
glucocorticoid
decreas
inflamm
edema
within
cn
thu
mri
indic
signific
brain
edema
signific
neurolog
deterior
occur
use
glucocorticoid
indic
dexamethason
sodium
phosphat
mgkg
iv
subcutan
everi
hour
follow
prednison
mgkg
mouth
twice
day
use
prednison
taper
week
possibl
high
dose
longterm
use
corticosteroid
avoid
immunosuppress
fip
fip
common
fatal
infecti
felin
diseas
caus
mutant
form
felin
enter
corona
viru
pyogranulomat
meningoenceph
meningomyel
seen
cn
involv
median
age
cat
fip
affect
cn
year
diagnosi
fip
often
challeng
cat
neurolog
fip
may
weight
loss
mentat
chang
seizur
ataxia
hyperesthesia
anterior
uveiti
hyphema
retin
hemorrhag
may
identifi
ophthalmolog
examin
serum
globulin
often
increas
seroneg
fip
may
seen
cat
low
titer
acut
fulmin
diseas
less
day
immun
complex
consumpt
mri
may
identifi
periventricular
chang
consist
ependym
third
fourth
ventricl
commonli
affect
secondari
hydrocephalu
may
also
identifi
csf
analysi
indic
increas
protein
valu
mean
gdl
neutrophil
pleocytosi
mean
cellsml
csf
antibodi
like
serum
origin
conflict
studi
make
definit
antibodi
origin
unknown
ratio
csf
antibodiesserum
antibodi
compar
csf
proteinserum
total
protein
greater
typic
suggest
intrathec
antibodi
product
howev
valu
greater
necessarili
impli
activ
cn
infect
prednisolon
therapi
typic
given
immunosuppress
dosag
mgkg
mouth
everi
hour
typic
mg
per
cat
mouth
everi
hour
cat
neurolog
fip
decreas
cn
inflamm
immunosuppress
prognosi
ultim
poor
benign
famili
juvenil
epilepsi
report
lagotto
romagnolo
dog
thought
recess
inherit
seizur
note
week
age
seizur
typic
respond
anticonvuls
therapi
discontinu
anticonvuls
often
possibl
sever
month
therapi
seizur
recurr
may
occur
adulthood
idiopath
epilepsi
classifi
recurr
seizur
without
appar
caus
interict
neurolog
examin
normal
result
blood
work
mri
csf
normal
seizur
typic
first
note
age
year
gener
tonicclon
seizur
typic
seen
although
focal
seizur
also
possibl
idiopath
epilepsi
sometim
use
impli
famili
epilepsi
inherit
beagl
golden
retriev
irish
wolfhound
english
springer
spaniel
labrador
retriev
vizsla
bernes
mountain
dog
boxer
belgian
tervuren
british
alsatian
keeshond
standard
poodl
autosom
recess
inherit
common
anticonvuls
therapi
typic
start
seizur
frequenc
increas
particularli
seizur
occur
within
month
baselin
period
help
determin
natur
seizur
frequenc
help
assess
respons
anticonvuls
therapi
howev
baselin
period
long
earli
antiepilept
treatment
may
lead
better
seizur
control
patient
cluster
seizur
statu
epilepticu
secondari
epilepsi
anticonvuls
therapi
start
without
delay
anticonvuls
therapi
target
decreas
frequenc
sever
seizur
increas
qualiti
life
advers
effect
possibl
choic
anticonvuls
mainten
therapi
tailor
individu
patient
patient
age
medic
histori
potenti
advers
effect
sever
seizur
disord
client
concern
must
consid
patient
histori
cluster
seizur
statu
epilepticu
progress
caus
seizur
author
typic
choos
phenobarbit
given
increas
efficaci
compar
anticonvuls
option
otherwis
young
patient
less
sever
seizur
disord
lave
author
often
choos
either
potassium
bromid
levetiracetam
given
decreas
chanc
hepatotox
client
unabl
consist
give
medic
multipl
time
day
start
potassium
bromid
reason
howev
dog
histori
gastrointestin
issu
author
typic
avoid
potassium
bromid
although
medic
benefit
risk
univers
perfect
anticonvuls
medic
may
need
adjust
optim
seizur
control
potenti
advers
effect
monotherapi
typic
prefer
initi
therapi
howev
seizur
disord
refractori
monotherapi
multidrug
therapi
indic
pursuit
adequ
seizur
control
import
educ
client
goal
anticonvuls
therapi
improv
seizur
control
minim
advers
effect
potenti
advers
effect
potenti
futur
need
multidrug
therapi
phenobarbit
histor
firstlin
treatment
seizur
dog
cat
phenobarbit
efficaci
anticonvuls
one
studi
report
efficaci
suspect
epilept
dog
phenobarbit
increas
seizur
threshold
decreas
spread
surround
neuron
enhanc
inhibitori
postsynapt
effect
gammaaminobutyr
acid
gaba
inhibit
glutam
activ
decreas
calcium
flux
across
neuron
membran
peak
level
achiev
hour
oral
administr
halflif
day
phenobarbit
metabol
increas
chronic
therapi
phenobarbit
typic
start
mgkg
mouth
everi
hour
dose
adjust
base
clinic
respons
advers
effect
serum
level
advers
effect
includ
sedat
ataxia
polyphagia
polyuriapolydypsia
pupd
increas
liver
enzym
potenti
liver
failur
increas
serum
level
mgml
therapeut
rang
mgml
routin
liver
monitor
recommend
increas
alkalin
phosphatas
alp
alanin
aminotransferas
alt
gamma
glutamyl
transferas
ggt
result
enzym
induct
rather
hepat
injuri
bile
acid
test
bilirubin
abdomin
ultrasound
affect
phenobarbit
therapi
one
studi
thu
bile
acid
test
bilirubin
abdomin
ultrasound
help
assess
liver
diseas
dog
receiv
phenobarbit
larger
increas
alt
compar
alp
concern
also
suggest
hepat
diseas
hepatotox
improv
phenobarbit
dose
lower
withdrawn
howev
advanc
liver
diseas
effect
irrevers
potenti
fatal
evalu
cbc
chemistri
week
start
therapi
month
later
everi
month
help
bile
acid
test
also
consid
period
hepat
enzym
increas
phenobarbit
shorter
compar
bromid
allow
quicker
manipul
plasma
level
make
good
choic
dog
frequent
seizur
phenobarbit
associ
rare
congenit
defect
bleed
problem
neonat
although
caution
recommend
phenobarbit
consid
like
safer
anticonvuls
small
amount
excret
matern
milk
thu
may
affect
nurs
anim
assess
hypothyroid
difficult
dog
receiv
phenobarbit
total
valu
may
significantli
decreas
dog
receiv
phenobarbit
total
chang
minim
thyroidstimul
hormon
tsh
increas
sever
month
phenobarbit
therapi
serum
cholesterol
also
increas
phenobarbit
administr
unclear
whether
decreas
clinic
signific
increas
thyroxin
monoiodin
cellular
level
may
occur
compens
hypothyroxinemia
tsh
valu
meaningless
valu
return
normal
within
week
phenobarbit
withdraw
valu
may
remain
decreas
week
cessat
phenobarbit
therapi
bromid
also
popular
firstchoic
secondchoic
anticonvuls
bromid
effect
epilept
dog
one
studi
anoth
studi
bromid
hyperpolar
neuron
replac
chlorid
ion
bromid
day
excret
kidney
increas
dietari
salt
intak
increas
renal
excret
advers
effect
bromid
includ
sedat
ataxia
pupd
polyphagia
gastrointestin
effect
possibl
associ
pancreat
lack
hepat
metabol
make
potassium
bromid
mg
kgd
food
good
choic
young
dog
therapeut
rang
mgml
dog
statu
epilepticu
cluster
seizur
long
bromid
make
difficult
use
effect
situat
drug
shorter
may
better
choic
load
dose
potassium
bromid
given
mgkg
mouth
total
cours
day
advers
effect
common
use
load
dose
bromid
given
cat
caus
pneumon
cat
pneumon
typic
revers
bromid
therapi
stop
reproduct
safeti
bromid
determin
levetiracetam
becom
increas
popular
past
decad
studi
limit
power
indic
respons
adjunct
levetiracetam
therapi
epilepsi
well
emerg
treatment
statu
epilepticu
cluster
seizur
levetiracetam
bind
synapt
vesicular
protein
levetiracetam
may
prevent
hypersynchron
burst
fire
seizur
propag
hour
dog
hour
cat
initi
dose
recommend
mgkg
mouth
time
day
howev
honeymoon
effect
note
sever
month
therapi
seizur
control
lost
honeymoon
phenomenon
pharmacokinet
evalu
led
recommend
start
dose
mgkg
mouth
time
day
extendedreleas
formul
also
avail
dose
mgkg
mouth
twice
day
extendedreleas
tablet
suitabl
small
dog
cat
tablet
cut
advers
effect
levetiracetam
seem
minim
sedationataxia
occur
uncommonli
sixtysix
percent
drug
excret
unchang
kidney
cytochrom
p
system
seem
involv
howev
concurr
phenobarbit
administr
shown
decreas
levetiracetam
decreas
levetiracetam
blood
level
thu
dog
phenobarbit
levetiracetam
concurr
may
requir
higher
dosag
levetiracetam
levetiracetam
excret
matern
milk
use
caution
nurs
anim
levetiracetam
use
caution
pregnant
anim
high
dosag
increas
embryofet
mortal
rabbit
rat
zonisamid
sulfonamidebas
anticonvuls
drug
also
becom
popular
past
decad
levetiracetam
report
limit
patient
number
publish
one
studi
indic
refractori
epilept
dog
respond
zonisamid
therapi
first
month
therapi
howev
respond
month
therapi
anoth
studi
indic
refractori
epilept
dog
respond
zonisamid
therapi
zonisamid
monotherapi
effect
epilept
dog
anoth
report
zonisamid
block
voltagedepend
sodium
channel
ttype
calcium
channel
hour
dog
hour
cat
zonisamid
metabol
hepat
microsom
enzym
also
renal
excret
reduc
concurr
phenobarbit
administr
zonisamid
administ
mgkg
mouth
twice
day
dog
higher
dose
rang
dog
also
receiv
phenobarbit
cat
given
mgkg
mouth
everi
hour
longer
zonisamid
typic
well
toler
anorexia
sedat
ataxia
common
advers
effect
acut
hepatopathi
within
week
start
zonisamid
therapi
recent
report
dog
renal
tubular
acidosi
also
report
recent
acidbas
chang
resolv
discontinu
zonisamid
zonisamid
given
pregnant
dog
ventricular
septal
defect
cardiomegali
valvular
arteri
anomali
occur
thu
zonisamid
recommend
use
pregnant
anim
unknown
whether
zonisamid
excret
matern
milk
gabapentin
bind
voltageg
calcium
channel
decreas
intracellular
calcium
influx
excret
unchang
kidney
hepat
metabol
dog
gabapentin
maximum
absorpt
occur
within
hour
administr
hour
dog
hour
cat
initi
dose
mgkg
mouth
time
day
six
refractori
epilept
dog
respond
gabapentin
therapi
one
studi
sedat
ataxia
common
advers
effect
liquid
formul
contain
xylitol
thu
given
dog
dog
requir
liquid
small
dose
drug
compound
contain
xylitol
gabapentin
teratogen
mice
rat
rabbit
thu
use
caution
avoid
pregnant
anim
gabapentin
excret
matern
milk
howev
amount
excret
thought
clinic
signific
pregabalin
gaba
analogu
structur
similar
gabapentin
pregabalin
higher
affin
subunit
neuron
voltageg
calcium
channel
gabapentin
pregabalin
hour
dog
hour
cat
pregabalin
administ
mgkg
mouth
time
day
seven
refractori
epilept
dog
respond
pregabalin
therapi
one
studi
advers
effect
includ
sedat
ataxia
common
thu
start
dose
mgkg
mouth
time
day
gradual
increas
dose
mgkg
recommend
dog
dose
mgkg
mouth
twice
day
recommend
cat
high
dosag
pregabalin
given
pregnant
rat
rabbit
caus
skelet
malform
offspr
pregabalin
also
excret
matern
milk
felbam
enhanc
inhibitori
effect
gaba
block
voltagedepend
sodium
channel
block
nmethyldaspart
receptor
dog
hour
administ
start
dose
mgkg
mgkg
mouth
time
day
dose
high
mgkg
mouth
time
day
may
requir
dog
felbam
caus
aplast
anemia
fatal
hepatopathi
peopl
thu
use
limit
dog
felbam
undergo
hepat
metabol
rest
excret
unchang
urin
advers
effect
dog
includ
hepat
effect
mild
thrombocytopenia
leukopenia
blood
dyscrasia
revers
stop
felbam
therapi
felbam
excret
matern
milk
although
overt
teratogen
effect
document
caution
recommend
pregnant
anim
benzodiazepin
potent
anticonvuls
enhanc
inhibitori
effect
gaba
diazepam
hour
dog
hour
cat
longer
diazepam
cat
make
possibl
candid
longterm
anticonvuls
therapi
howev
use
oral
diazepam
limit
potenti
risk
severefat
liver
diseas
cat
strict
monitor
requir
diazepam
use
oral
cat
toler
develop
mainten
use
benzodiazepin
thu
short
durat
action
dog
develop
toler
limit
use
benzodiazepin
emerg
set
diazepam
mgkg
iv
mgkg
rectal
recommend
immedi
treatment
seizur
absorpt
benzodiazepin
administ
rectal
variabl
result
question
efficaci
concurr
phenobarbit
administr
increas
metabol
diazepam
thu
higher
dose
rang
recommend
rectal
diazepam
dog
concurr
receiv
phenobarbit
therapi
diazepam
mgkgh
may
administ
constantr
infus
cri
dose
titrat
base
seizur
control
sedat
midazolam
water
solubl
good
choic
emerg
treatment
cri
need
peripher
cathet
via
intramuscular
inject
midazolam
dog
minut
dose
mgkg
recommend
intraven
intramuscular
bolu
immedi
seizur
control
dosag
mg
kgh
given
cri
benzodiazepin
use
stop
acut
seizur
import
also
administ
longer
act
anticonvuls
prevent
seizur
diazepam
caus
congenit
abnorm
given
first
trimest
pregnanc
avoid
possibl
pregnant
anim
benzodiazepin
metabolit
excret
matern
milk
thu
affect
nurs
anim
clorazep
metabol
nordiazepam
hour
dog
toler
develop
readili
compar
diazepam
clorazep
may
help
shortterm
control
breakthrough
seizur
dose
mgkg
mouth
time
day
recommend
clorazep
increas
phenobarbit
level
serum
phenobarbit
level
monitor
use
week
start
clorazep
therapi
clorazep
use
extrem
caution
aggress
anim
metabolit
nordiazepam
distribut
milk
thu
may
affect
nurs
anim
use
acepromazin
dog
histori
seizur
commonli
recommend
possibl
decreas
seizur
threshold
use
howev
evid
warrant
contraind
use
acepromazin
patient
seizur
lack
use
acepromazin
patient
seizur
unlik
result
seizur
retrospect
studi
evalu
dog
histori
seizur
given
acepromazin
sedat
preanesthet
none
dog
seizur
within
hour
use
therapeut
level
toxic
level
guidelin
extrapol
peopl
rang
base
popul
statist
may
accur
reflect
whether
individu
canin
felin
patient
control
nonetheless
help
optim
anticonvuls
therapi
assess
risk
factor
therapi
help
gaug
second
anticonvuls
may
need
determin
anticonvuls
level
benefici
dose
chang
need
inadequ
seizur
control
toxic
formula
desir
blood
levelcurr
blood
level
time
current
dose
equal
newli
recommend
dose
refractori
patient
becom
control
allow
identif
therapeut
level
patient
provid
seizur
disord
worsen
patient
sensit
toxic
effect
anticonvuls
commonli
bromid
obtain
blood
level
soon
clinic
sign
toxic
abat
identifi
toxic
level
patient
evalu
blood
level
may
import
patient
current
histor
well
control
free
advers
effect
patient
receiv
phenobarbit
ideal
level
obtain
reach
steadi
state
given
risk
hepatotox
level
greater
mgml
addit
serial
phenobarbit
level
everi
month
benefit
hepat
metabol
chang
peak
trough
phenobarbit
level
recommend
past
howev
patient
receiv
phenobarbit
clinic
signific
chang
peak
trough
level
one
studi
thu
singl
sampl
typic
suffici
identifi
time
sampl
collect
rel
dose
help
level
high
refer
rang
toxic
avoid
therapeut
level
levetiracetam
zonisamid
pregabalin
unknown
dog
time
thu
routin
monitor
level
typic
done
usag
drug
bromid
level
affect
cl
increas
dietari
cl
intraven
fluid
contain
cl
increas
renal
excret
bromid
thu
lower
serum
bromid
level
patient
receiv
bromid
therapi
may
lose
seizur
control
result
chang
diet
intraven
fluid
contrast
decreas
dietari
cl
may
lead
toxic
sedat
ataxia
renal
bromid
excret
reduc
serum
bromid
level
subsequ
increas
thu
dietari
chang
minim
patient
receiv
bromid
therapi
transit
one
anticonvuls
anoth
sever
factor
may
influenc
recommend
transit
signific
advers
effect
appar
reason
add
addit
drug
continu
initi
anticonvuls
mainten
dose
initi
anticonvuls
drug
withdrawn
taper
cours
sever
month
often
difficult
definit
know
effect
initi
drug
wean
initi
drug
sever
month
may
help
prevent
withdraw
seizur
sedat
ataxia
note
addit
new
anticonvuls
either
drug
may
taper
limit
advers
effect
seizur
control
success
without
advers
effect
mainten
therapi
multipl
drug
may
warrant
thu
initi
drug
may
withdrawn
second
third
drug
implement
advers
effect
taper
drug
like
advers
effect
recommend
advers
effect
mild
moder
concern
taper
drug
phenobarbit
may
done
everi
week
time
potassium
bromid
may
reduc
quickli
time
longer
rapid
taper
withdraw
necessari
adjust
medic
sever
advers
effect
exist
therapi
situat
exist
therapi
stop
immedi
cours
day
import
concurr
start
anoth
pediatr
seizur
disord
dog
cat
anticonvuls
shorter
steadi
state
rapidli
achiev
furthermor
addit
drug
differ
profil
advers
effect
